He et al. [137], in a retrospective cohort study, evaluated in a sample of COVID-19 patients whether some metabolomic factors could be involved in the regulation of myostatin expression during COVID-19 infections and whether this myokine could be associated with the ordinary IR and lipid dysregulations of the disease. The gene discussed is MSTN; the disease is COVID-19.